Ocugen, Inc. Shares of Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • August 17th, 2020 • Ocugen, Inc. • Biological products, (no disgnostic substances) • New York
Ocugen, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. and Oppenheimer & Co. Inc. (each, an “Agent” and together, the “Agents”), as follows:
